From api.bing.com
()
 |
Article does not exist. |
The first human clinical trials for a retinal implant have been a success – allowing those who had been blind to see again. About 200,000 people in the United States and Europe suffer from retinitis pigmentosa, a genetic disease that causes ...
- Eye implants may offer a cure for blindness (api.bing.com)
Vizio Optic, a global award-winning designer eyeglasses shop and online eyewear retailer, is proud to announce the addition of eyewear styles from the new Alain Mikli collection. The French designer is world-renowned for carefully handcrafting each and ...
From api.bing.com
()
- Hemoglobin A1c, BP With Eye Exam for Diabetic Retinopathy (api.bing.com)
Background:
Retinal degenerations, such as age-related macular degeneration (AMD) and retinitis pigmentosa (RP), are characterized by photoreceptor loss and anomalous remodeling of the surviving retina that corrupts visual processing and poses a barrier to late-stage therapeutic interventions in particular. However, the molecular events associated with retinal remodeling remain largely unknown. Given our prior evidence of ionotropic glutamate...
More perspectives...
From biomedcentral.com
()
Retinalyze Analytics will initially be used for age-related macular degeneration ("AMD (News - Alert)"), a progressive eye disease affecting more than 15 million Americans, with over 200,000 new cases diagnosed each year. AMD is the leading ...
From api.bing.com
()
- AMD awareness focuses on protecting and enhancing vision (api.bing.com)
- AFER Announces 2011 Genentech Fellowship Recipients (newswise.com)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Altheos, Inc., announced today the dosing of the first patient in a Phase 2a clinical trial of its lead investigational candidate, ATS907, a Rho kinase (ROCK)-selective inhibitor in development as a next-generation eye drop for the reduction of elevated intraocular pressure (IOP) in primary open angle glaucoma and ocular hypertension. ATS907 is one of a series of ROCK inhibitor compounds licensed...
From businesswire.com
()
- Novartis receives Chinese OK for eye drug Lucentis (api.bing.com)
- Japan priest fights invisible demon: radiation (microsite.reuters.com)
Overview
Health issues related to your eyes, vision, and sight
Sorted by: Top Rated
